We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
A community-based, randomised placebo-controlled trial
Helping public health practitioners conducting evaluations – using process evaluations to explain how complex interventions work.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use an economic evaluation to evaluate your digital health product.
The What Works Network uses evidence to improve the design and delivery of public services.
For the treatment of severe acute malnutrition in children: a noninferiority individually randomized controlled efficacy clinical trial in Malawi
A collaborative project to design and evaluate a biological system, called a biobed, for the disposal of pesticides
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
Helping public health practitioners conducting evaluations – what the evaluation is, when it should be undertaken and the different types of evaluation available.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Appendix to the assessing fitness to drive guide for medical professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).